info@synchemia.com | sales@synchemia.com 
9766925136 
Brimonidine Nitroso Impurity 2
Specifications
Product name
Brimonidine Nitroso Impurity 2
SRC CAT No
SRC-N014466
CAS No
NA
Mol.F.
C11H9BrN6O
Mol.Wt.
321.13 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine is used to relieve redness in the eyes caused by minor eye irritations (such as smog, swimming, dust, or smoke).Brimonidine Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso Impurity 2 . We supply Brimonidine Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Related Products
N-Nitroso Gabapentin EP Impurity A | Nitroso Gabapentin Lactam Impurity
| CAT No | SRC-N0141763 |
| CAS No | 856068-98-9 |
| Mol.F. | C9H14N2O2 |
| Mol.Wt. | 182.2 g/mol |
| INV STATUS | In Stock |
Dasatinib Dichloro Nitroso Impurity
| CAT No | SRC-N0141764 |
| CAS No | NA |
| Mol.F. | C16H12Cl2N6O2S |
| Mol.Wt. | 423.3 |
| INV STATUS | CUSTOM SYNTHESIS |
Dasatinib Nitroso Impurity 3
| CAT No | SRC-N0141765 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O4S |
| Mol.Wt. | 533.0 |
| INV STATUS | CUSTOM SYNTHESIS |
Dasatinib Nitroso Impurity 4
| CAT No | SRC-N0141766 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O4S |
| Mol.Wt. | 533.0 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Levodopa Impurity 1
| CAT No | SRC-N0141767 |
| CAS No | NA |
| Mol.F. | C12H12N2O7 |
| Mol.Wt. | 296.2 |
| INV STATUS | CUSTOM SYNTHESIS |
N,N-Dinitroso Levofloxacin EP Impurity G
| CAT No | SRC-N0141768 |
| CAS No | NA |
| Mol.F. | C16H16FN5O6 |
| Mol.Wt. | 393.3 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Levofloxacin EP Impurity G (Possibility 1)
| CAT No | SRC-N0141769 |
| CAS No | NA |
| Mol.F. | C16H17FN4O5 |
| Mol.Wt. | 364.3 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Levofloxacin EP Impurity G (Possibility 2)
| CAT No | SRC-N0141770 |
| CAS No | NA |
| Mol.F. | C16H17FN4O5 |
| Mol.Wt. | 364.3 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Levofloxacin Impurity 2
| CAT No | SRC-N0141771 |
| CAS No | NA |
| Mol.F. | C15H15FN4O5 |
| Mol.Wt. | 350.3 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Levofloxacin Impurity 3
| CAT No | SRC-N0141772 |
| CAS No | NA |
| Mol.F. | C15H14F4N2O5 |
| Mol.Wt. | 378.3 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Levofloxacin Impurity 4
| CAT No | SRC-N0141773 |
| CAS No | NA |
| Mol.F. | C15H14FN3O5 |
| Mol.Wt. | 335.3 |
| INV STATUS | CUSTOM SYNTHESIS |
Levofolinate Nitroso Impurity 4
| CAT No | SRC-N0141774 |
| CAS No | NA |
| Mol.F. | C20H22N8O8 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
Levomefolate Nitroso Impurity 4 | N-Nitroso Levomefolic acid 2
| CAT No | SRC-N0141775 |
| CAS No | NA |
| Mol.F. | C20H24N8O7 |
| Mol.Wt. | 488.5 |
| INV STATUS | CUSTOM SYNTHESIS |
Dinitroso L-5 methyltetrahydrofolate
| CAT No | SRC-N0141776 |
| CAS No | NA |
| Mol.F. | C20H21N9O8 |
| Mol.Wt. | 515.4 |
| INV STATUS | CUSTOM SYNTHESIS |
Mononitroso Methyltetrahydrofolate
| CAT No | SRC-N0141777 |
| CAS No | NA |
| Mol.F. | C20H22N8O7 |
| Mol.Wt. | 486.4 |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitrosopiperazine L-5 methyltetrahydrofolate
| CAT No | SRC-N0141778 |
| CAS No | NA |
| Mol.F. | C20H22N8O7 |
| Mol.Wt. | 486.4 |
| INV STATUS | CUSTOM SYNTHESIS |
